Challenges and new discoveries in the treatment of leishmaniasis
References (64)
Leishmaniasis
Lancet
(1999)Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis)
Trans R Soc Trop Med Hyg
(1984)Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar India
Trans R Soc Trop Med Hyg
(1983)- et al.
Amphotericin versus pentamidine in antimony-unresponsive kala-azar
Lancet
(1992) - et al.
Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar
Lancet
(1994) - et al.
Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate
Trans R Soc Trop Med Hyg
(1990) - et al.
Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom
Trans R Soc Trop Med Hyg
(1992) - et al.
Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable antileishmanial drugs: a community-based study
Int J Infect Dis
(2000) Evaluation of Allopurinol in treatment of kala-azar occurring in North Bihar India
Trans R Soc Trop Med Hyg
(1983)- et al.
The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica
Trans R Soc Trop Med Hyg
(1990)
Treatment of kala-azar with oral fluconazole
Lancet
(1996)
Characterization of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)
Int J Antimicrob Agents
(2003)
Topical treatment of cutaneous leishmaniasis
J Invest Dermatol
(1986)
Treatment of “Old World” cutaneous leishmaniasis with aminosidine ointment: results of an open study in London
Trans R Soc Trop Med Hyg
(1994)
Mucosal Leishmaniasis in an Indian AIDS patient
Lancet Infect DIS
(2004)
(1990)
The treatment of kala-azar: new approach to an old problem
Ind J Med Res
(1981)
Leishmaniasis in the Indian subcontinent
Post-kala-azar dermal leishmaniasis
Int J Dermatol
(1995)
Leishmaniasis in HIV infection
J Postgrad Med
(2003)
Transfusion-transmitted Kala-azar in India
Transfusion
(1996)
Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study
Am J Trop Med Hyg
(1991)
Drug resistance in kala-azar: an overviews
Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies
Am J Trop Med Hyg
(1992)
Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years
Clin Infect Dis
(1997)
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis
Clin Infect Dis
(1994)
Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis
Clin Infect Dis
(1996)
Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial
J Assoc Physicians India
(1991)
Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine
Am J Trop Med Hyg
(1994)
Treatment of visceral leishmaniasis
Med Microbiol Immunol (Berl)
(2001)
Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life
Indian J Pediatr
(1993)
Cited by (256)
Leishmaniasis
2022, Encyclopedia of Infection and ImmunityTherapeutic effects of the as-synthesized polylactic acid/chitosan nanofibers decorated with amphotricin B for in vitro treatment of Leishmaniasis
2021, Journal of Saudi Chemical SocietySynthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity
2024, Archiv der Pharmazie
Copyright © 2004 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.